UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Q: What does CUSIP M96088105 represent in this 13F holders report?

CUSIP M96088105 is the security identifier for URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in Q2 2020?

83 institutional investors reported URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: M96088105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding: 46,986,408
Total 13F shares: 14,672,947
Share change: +680,389
Total reported value: $381,998,824
Put/Call ratio: 168%
Price per share: $26.12
Number of holders: 83
Value change: +$28,263,022
Number of buys: 51
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP M96088105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MENORA MIVTACHIM HOLDINGS LTD.	13F	Company	6.3%	2,954,699	$52,712,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	3%	1,396,976	$24,922,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.3%	1,095,385	$19,543,000	—	31 Mar 2020	13F
Wildcat Capital Management, LLC	13F	Company	1.9%	900,148	$16,058,000	—	31 Mar 2020	13F
Phoenix Financial Ltd.	13F	Company	1.9%	883,468	$15,390,000	—	31 Mar 2020	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	1.6%	738,302	$13,171,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	1.4%	672,912	$12,005,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	1.4%	669,003	$11,935,000	—	31 Mar 2020	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	1.1%	529,388	$9,444,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.84%	396,145	$7,067,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.67%	314,603	$5,613,000	—	31 Mar 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.65%	306,425	$5,467,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.58%	270,833	$4,831,000	—	31 Mar 2020	13F
Horton Capital Management, LLC	13F	Company	0.54%	251,619	$4,489,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.49%	230,027	$4,104,000	—	31 Mar 2020	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	0.47%	222,776	$3,974,000	—	31 Mar 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.4%	187,419	$3,343,000	—	31 Mar 2020	13F
Pier Capital, LLC	13F	Company	0.32%	150,184	$2,679,000	—	31 Mar 2020	13F
Prosight Management, LP	13F	Company	0.31%	146,179	$2,608,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	137,585	$2,454,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.28%	130,448	$2,328,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.25%	119,537	$2,133,000	—	31 Mar 2020	13F
SG Americas Securities, LLC	13F	Company	0.22%	101,597	$1,812,000	—	31 Mar 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.21%	100,813	$1,799,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.2%	93,110	$1,661,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.17%	81,225	$1,450,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.15%	68,278	$1,218,000	—	31 Mar 2020	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.11%	52,550	$937,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.1%	48,196	$860,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	47,051	$839,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	41,898	$747,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	40,564	$724,000	—	31 Mar 2020	13F
ALPS ADVISORS INC	13F	Company	0.08%	38,139	$680,000	—	31 Mar 2020	13F
Coastal Bridge Advisors, LLC	13F	Company	0.08%	37,000	$660,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.07%	34,500	$615,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.06%	30,525	$545,000	—	31 Mar 2020	13F
MEITAV INVESTMENT HOUSE LTD	13F	Company	0.06%	30,406	$544,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	30,423	$543,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.05%	24,749	$442,000	—	31 Mar 2020	13F
Palo Alto Investors LP	13F	Company	0.05%	24,500	$437,000	—	31 Mar 2020	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.05%	23,590	$428,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	23,548	$420,000	—	31 Mar 2020	13F
Altshuler Shaham Ltd	13F	Company	0.05%	23,501	$419,000	—	31 Mar 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.05%	21,942	$391,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	21,900	$391,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.05%	21,801	$388,930	—	31 Mar 2020	13F
ARK Investment Management LLC	13F	Company	0.04%	16,821	$300,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	16,300	$291,000	—	31 Mar 2020	13F
BANK HAPOALIM BM	13F	Company	0.03%	14,481	$258,000	—	31 Mar 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.03%	14,469	$258,000	—	31 Mar 2020	13F

Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q2 2020

As of 30 Jun 2020, UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,672,947 shares. The largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., CREDIT SUISSE AG/, Wildcat Capital Management, LLC, Phoenix Holdings Ltd., Migdal Insurance & Financial Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, STATE STREET CORP, and Horton Capital Management, LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.